RecruitingNCT00710112

Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants


Sponsor

Medical College of Wisconsin

Enrollment

1,100 participants

Start Date

Jun 1, 2006

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to determine if sequence variations in genes involved in the development and function of vulnerable organs increases susceptibility to chronic lung disease (CLD) and other diseases affecting premature infants, such as necrotizing enterocolitis (NEC), sepsis, patent ductus arteriosus (PDA) and intraventricular hemorrhage (IVH). The study will also determine whether measurement of certain biomarkers in serum will identify infants who will develop these complications of prematurity. Previous studies from this institution and others have identified genetic variants in some genes, such as toll like receptor genes are associated with higher risk of CLD or NEC. The interaction of these variants with other gene variants that can influence the risk of these diseases remains unclear.


Eligibility

Inclusion Criteria1

  • Infants born weighing less than 1500 grams

Exclusion Criteria2

  • Infants born with congenital heart disease (other than patent ductus arteriosus)
  • major congenital anomalies of the GI tract, respiratory tract, or kidneys

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICgene variations

comparing variations in genes in infants who develop chronic lung disease and other diseases of prematurity and those who do not.


Locations(1)

Children's Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00710112


Related Trials